DvH Ventures backs MedTech OneTwenty to revolutionize diabetes care
OneTwenty is a Zurich-based startup at the vanguard of diabetes technology. With a mission to elevate diabetes care, the company specializes in developing AI-driven algorithms that enhance the functionality of diabetes devices. OneTwenty's proprietary technology stands as the first in the market capable of navigating the intricacies of human metabolism, offering an autonomous and streamlined approach to diabetes management.
Founded by Michael Rottmann and Dr. med. Julian M. Stiels // Investment in December 2023